Assessment of real-world efficacy and safety of basal insulin plus rapid-acting insulin vs basal insulin treatment among patients with type 2 diabetes in the UK

Sep-15

Endocrinology Pharmacoepidemiology

AUTHORS : Jay Lin, Novosys Health, 7 Crestmont CT, Flemington, NJ 08822, USA – Email: jay.lin@novosyshealth.com

JOURNAL : Diabetologia

REFERENCE: 58(S1):S76-S77

DOI : 10.1007/s00125-015-3687-4

Read more